-

Scientific Programme

 

Sunday October 7th, 2007

 

 

18:30

 

Opening lecture

 

 

 

Impact of conjugate pneumococcal vaccine on pneumococcal pneumonia:implications for pandemic influenza preparedness.

 

Keith Klugman

Atlanta, USA

 

20:00

 

Dinner

 

 

 

Monday October 8th, 2007

 

 

Physiology and pathogenicity factors of S. pneumoniae

 

 

 

 

 

Morning session: plenary lectures

 

 

 

 

 

 

 

 

Chairpersons:

 

L. Sigve HåvarsteinErnesto García

 

08:30-09:30

Pneumococcal virulence factors and their role in disease.

 

Tim J.Mitchell

Glasgow,UK

 

09:30-10:30

Pneumococcal fratricide: possible impact on horizontal gene transfer and virulence.

 

Leiv Sigve Håvarstein

As, Norway

 

10:30-11:00

Coffee break

 

 

11:00-12:00

Pneumococcal peptidoglycan hydrolases: from phage to bacteria (or vice versa).

Ernesto García

Madrid, Spain

 

12:00-13:00

Capsular polysaccharide biosynthesis in the pneumococcus.

 

 

Janet L. Yother Birmingham,USA

 

13:00-14:30

Lunch

 

 

 

 

 

 

14:30

Afternoon session: abstract presentations and discussion around the poster boards

 

 

 

15: Identification of Conditionally Essential Genes of Streptococcus pneumoniae by Genomic Array Footprinting.

 

Esther Bootsma

Netherlands

 

 

17: Streptococcus pneumoniae contain three rlrA pilus variants that are clonally related.

 

Michele Barocchi

Italy

 

 

26: Pilus-related Sortase SrtB of S.pneumoniae catalyzes specific transpeptidation reactions in Vitro.

 

Werner Pansegrau Italy

 

 

27: Competence induced fratricide in pneumococci.

 

Vegard Eldholm

Norway

 

 

23: Pneumolysin and autolysin genes in nonencapsulated and encapsulated pharyngeal Streptococcus pneumoniae isolates from young Finnish men.

 

Paula Asumaniemi

Finland

 

 

20: The association of MBL2 gene polymorphisms and the carriage of Streptococcus pneumoniae in asthmatic and nonasthmatic young men.

 

Aino Rantala

Finland

 

 

29: Protective immune response cytokine profile to S. pneumoniae protein with vaccine potential.

 

Y. Mizrachi Nebenzahl Israel

 

 

18: Rapid identification of Streptococcus pseudopneumoniae from Streptococcus pneumoniae and other "viridans streptococci" using PCR-RFLP (PCR-Restriction fragment lengh polymorphism).

 

Margaret Ip

Hong Kong

 

 

4: RT-PCR detection of S. pneumoniae in patients with invasive bacterial disease after antibiotic therapy.

 

Sigrid Heuberger

Austria

 

19:30

 

Dinner

 

 

 

 

Tuesday October 9th, 2007

 

 

Antimicrobial resistance of S. pneumoniae

 

 

 

Morning session: plenary lectures

 

 

 

 

 

Chairpersons:

 

Daniel Musher

"N. N."

 

08:00-09:00

A fresh look at the definition of susceptibilityof Streptococcus pneumoniae to beta-lactam antibiotics.

 

Daniel Musher

Houston, USA

 

09:00-10:00

Update on macrolide resistance.

 

Josefina Liñares Barcelona, Spain

 

 

 

 

10:00-10:30

 

 

 

Coffee break

 

 

10:30-11:30

Resistance to fluoroquinolones and fitness cost.

 

Keith Klugman

Atlanta, USA

 

11:30-12:30

Relationship between antimicrobial resistance and virulence.

 

Jefferey N. Weiser

Philadelphia, USA

 

12:30-13:30

Lunch

 

 

13:30-17:30

Excursion

 

 

18:00-20:00

Late afternoon session: abstract presentations and discussion around the poster boards

 

 

 

5: mef positive Streptococcus pneumoniae Spanish clinical isolates: population structure analysis and its relationship with tetracycline resistance.

 

Elia Gomez

Spain

 

 

12: Streptococcus pneumoniae drug resistance in non-vaccine serotypes isolated from children vaccinated with the heptavalent conjugate vaccine (PCV7).

 

Nelson Frazão Portugal

 

 

30: Penicillin-resistance of invasive Streptococcus pneumoniae increased in Finland in 2005-2006.

 

A. VIrolainen Julkunen

Finland

 

 

25: Study of the resistant Streptococcus pneumoniae strains. isolated in Romania between January 2001- June 2007.

 

Marina Pana

Romania

 

 

28: Rate of nasopharyngeal carriage, antimicrobial resistance and serotype of Streptococcus pneumoniae among children in Central Greece.

A. Tatsiopoulos

Greece

 

 

 

33: Activity of Third Generation Cephalosporins against Penicillin/Amoxicillin Non-Susceptible S. pneumoniae Isolates from 2007 in Spain.

 

Lorenzo Aguilar

Spain

 

 

20:00

 

Dinner

 

 

 

Wednesday October 10th, 2007

 

 

Clinical management and epidemiology of S. pneumoniae

 

 

 

Morning session: plenary lectures

 

 

 

 

 

 

Chairpersons:

 

Ron Dagan

Ake Örtqvist

 

08:30-09:30

Nasopharyngeal colonisation.

 

HelenaMäkel Helsinki, Finland

 

09:30-10:30

Serotypes replacement.

 

Ron Dagan

Beer-Sheva, Israel

 

10:30-11:00

Coffee break

 

 

11:00-12:00

Vaccines.

 

Ake Örtqvist

Stockholm, Sweden

 

12:00-13:00

Treatment of multidrug resistant S. pneumoniae.

 

Javier Garau Barcelona, Spain

 

13:00-14:30

Lunch

 

 

14:30

Afternoon session:abstract presentations and discussion around the poster boards

 

 

 

14: Temporal Trends in Pneumococcal Parapneumonic Empyema in Children in Spain: a Nationwide Study.

 

Esther Calbo

Spain

 

16: Serotyping of Streptococcus pneumoniae by PCR ? expansion of the method to identify the Hungarian serotypes.

 

Orsolya Dobay Hungary

 

 

19: Epidemiology of S. pneumoniae in sepsis and meningitis in Lombardy (Italy).

 

Laura Daprai

Italy

 

 

13: Emergence of serotype 1 Streptococcus pneumoniae colonizing healthy children in Portugal in the 7-valent conjugate vaccination era.

 

Sónia Nunes

Portugal

 

24: Incidence and serotype distribution of isolates causing invasive pneumococcal disease in Denmark, 1938-2006.

 

Zitta B. Harbo, Denmark

 

 

11: Dramatic changes in the pneumococcal nasopharyngeal flora of preschool children in Portugal following the introduction of the seven-valent pneumococcal conjugate vaccine (PCV7).

 

Raquel Sa-Leao, Portugal

 

 

31: Does Protein Binding Preclude Antipneumococcal Activity of a Highly Bound Cephalosporin?: A Cefditoren Pharmacodynamic Simulation.

 

Lorenzo Aguilar

Spain

 

 

32: Monte Carlo Simulation Describing the Pharmacodynamic Profile of 400 mg Cefditoren-Pivoxil Administered after Meals.

 

Maria-Jose Gimene, Spain

 

 

18:00

Closing lecture

 

 

 

A perspective on the problem of S. pneumoniae.

 

David Fedson

Sergy Haut,France

Search:
 inside this site:
   
   
 Go
 
rss/atom
CH-1015 Lausanne  - Switzerland  -  Tel. +41 21 692 56 00  -  Fax +41 21 692 56 05
Swiss University